Leap therapeutics to host virtual kol event to discuss sirexatamab (dkn-01) in second-line patients with advanced microsatellite stable colorectal cancer

Virtual kol event on wednesday, april 23, 2025, at 2:30 p.m. et cambridge, mass.
LPTX Ratings Summary
LPTX Quant Ranking